First Time Loading...

Collegium Pharmaceutical Inc
NASDAQ:COLL

Watchlist Manager
Collegium Pharmaceutical Inc Logo
Collegium Pharmaceutical Inc
NASDAQ:COLL
Watchlist
Price: 37.51 USD Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

COLL Price Targets Summary
Collegium Pharmaceutical Inc

Wall Street analysts forecast COLL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COLL is 40.8 USD with a low forecast of 39.39 USD and a high forecast of 43.05 USD.

COLL Lowest Forecast
Wall Street Target
39.39 USD
5% Upside
COLL Average Forecast
Wall Street Target
40.8 USD
9% Upside
COLL Highest Forecast
Wall Street Target
43.05 USD
15% Upside
Lowest
Price Target
39.39 USD
5% Upside
Average
Price Target
40.8 USD
9% Upside
Highest
Price Target
43.05 USD
15% Upside
Collegium Pharmaceutical Inc Competitors:
Price Targets
R
RHONEMA
Rhone Ma Holdings Bhd
14% Upside
002020
Zhejiang Jingxin Pharmaceutical Co Ltd
12% Upside
1760
Panion & BF Biotech Inc
13% Upside
ALKEM
Alkem Laboratories Ltd
1% Upside
R
RHONEMA
Rhone Ma Holdings Bhd
14% Upside
002020
Zhejiang Jingxin Pharmaceutical Co Ltd
12% Upside
1760
Panion & BF Biotech Inc
13% Upside
ALKEM
Alkem Laboratories Ltd
1% Upside
ALIM
Alimera Sciences Inc
124% Upside
K
102940
Kolon Life Science Inc
503% Upside
S
300233
Shandong Jincheng Pharmaceutical Group Co Ltd
71% Downside
H02
Haw Par Corporation Ltd
76% Upside

Revenue
Forecast

Revenue Estimate
Collegium Pharmaceutical Inc

The compound annual growth rate of Collegium Pharmaceutical Inc's revenue for the next 3 years is 1%.

N/A
Past Growth
1%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Collegium Pharmaceutical Inc

The compound annual growth rate of Collegium Pharmaceutical Inc's operating income for the next 3 years is 10%.

N/A
Past Growth
10%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Collegium Pharmaceutical Inc

The compound annual growth rate of Collegium Pharmaceutical Inc's net income for the next 3 years is 45%.

N/A
Past Growth
45%
Estimated Growth
Estimates Accuracy
-29%
Average Miss
What are analyst estimates?

See Also

Summary
COLL intrinsic value, competitors valuation, and company profile.
DCF Valuation
COLL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
COLL stock valuation using valuation multiples.
Wall Street Estimates
COLL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
COLL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is COLL's stock price target?
Price Target
40.8 USD

According to Wall Street analysts, the average 1-year price target for COLL is 40.8 USD with a low forecast of 39.39 USD and a high forecast of 43.05 USD.

What is Collegium Pharmaceutical Inc's Revenue forecast?
Projected CAGR
1%

The compound annual growth rate of Collegium Pharmaceutical Inc's revenue for the next 3 years is 1%.

What is Collegium Pharmaceutical Inc's Operating Income forecast?
Projected CAGR
10%

The compound annual growth rate of Collegium Pharmaceutical Inc's operating income for the next 3 years is 10%.

What is Collegium Pharmaceutical Inc's Net Income forecast?
Projected CAGR
45%

The compound annual growth rate of Collegium Pharmaceutical Inc's net income for the next 3 years is 45%.

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.